Department of Pharmacology and Neuroscience
Total Page：16
File Type：pdf, Size：1020Kb
Institutional Molecul Biosafety Committee
ar Biology and Immunology
MEMORANDUM
To Adnan Dibas, Ph.D. Department of Pharmacology and Neuroscience
From Rance Berg, Ph.D. IBC, Chair
Maya P. Nair, Ph.D. Bio Safety Officer
Date: September 26, 2014
Subject: IBC/rDNA/AD /1 Project Title _ Understanding trafficking of nuclear and cytosolic proteins in cells
Your protocol identified above has been approved by the BSO/IBC effective September 19, 2014. Please reference this protocol number in all research activities covered by this application. Project Containment remains at BSL2/ ABSL2. Please contact us if you have any questions or any additional changes in the protocol.
If this research activity is to be continued beyond the third anniversary, a new Pathogen Safety Plan must be submitted to IBC for review.
Cc: file
Institutional Molecul Biosafety Committee
ar Biology and Immunology
MEMORANDUM
To Weiming Mao, Ph.D. Department of Cell Biology and Immunology
From Rance Berg, Ph.D. IBC, Chair
Maya P. Nair, Ph.D. Bio Safety Officer
Date: September 09, 2014
Subject: IBC/rDNA/WM /1 Protocol Title: Crosstalk of TGF-bet and Wnt pathways in the trabecular meshwork/Determination of cross-linked actin network associated proteins
Your protocol identified above has been approved by the BSO/IBC effective 7/1/2014. Please reference this protocol number in all research activities covered by this application. Project Containment remains at BSL2. Please contact us if you have any questions or any additional changes in the protocol.
If this research activity is to be continued beyond the third anniversary, a new Pathogen Safety Plan must be submitted to IBC for review.
Cc: file
Institutional Molecul Biosafety Committee
ar Biology and Immunology
MEMORANDUM
To Raghu Krishnamoorthy, Ph.D. Department of Cell Biology and Immunology
From Rance Berg, Ph.D. IBC, Chair
Maya P. Nair, Ph.D. Bio Safety Officer
Date: September 09, 2014
Subject: IBC/rDNA/RK /1
Protocol Title: Role of endothelin receptors in glaucomatous optic neuropathy
Your protocol identified above has been approved by the BSO/IBC effective 8/8/2014. Please reference this protocol number in all research activities covered by this application. Project Containment remains at BSL1. Please contact us if you have any questions or any additional changes in the protocol.
If this research activity is to be continued beyond the third anniversary, a new Pathogen Safety Plan must be submitted to IBC for review.
Cc: file